Correction to: Well-preserved liver function enhances the clinical impact of curative-intent subsequent treatment during lenvatinib treatment for unresectable hepatocellular carcinoma.
Kawamura Y, Akuta N, Shindoh J, Matsumura M, Okubo S, Tominaga L, Fujiyama S, Hosaka T, Saitoh S, Sezaki H, Suzuki F, Suzuki Y, Ikeda K, Arase Y, Hashimoto M, Kozuka T, Kumada H.
Kawamura Y, et al. Among authors: hashimoto m.
Clin J Gastroenterol. 2023 Oct;16(5):791. doi: 10.1007/s12328-023-01825-7.
Clin J Gastroenterol. 2023.
PMID: 37392310
No abstract available.